$ 73.69
Updated 15/12/2018
Change % 0.00% Stock price unchanged
Change 0.00 Stock price unchanged
Volume 2,343,637
High $ 74.44
Low $ 73.60
Open $ 74.38
ISIN
Prev close $ 74.49
# of shares 55.05M
Market cap 4,056.41M USD
Intraday

Market closed
Tesaro Inc
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  73.69 -0.5% Stock price decreasing 110.8% Stock price increasing 110.3% Stock price increasing 85.3% Stock price increasing -8.6% Stock price decreasing
Powered by TradingView

News about Tesaro Inc

  • English
  • Regulatory news
14 Dec
 
14 Dec
 
13 Dec
 
12 Dec
 
11 Dec
 
10 Dec
 
09 Dec
 
07 Dec
 
07 Dec
 
06 Dec
 

Company profile

Tesaro is an oncology-focused biopharmaceutical company with a focus on developing treatments for cancer. Upon successful development and regulatory approval of any of its product candidates, the company intends to pursue commercialization in key product markets, including North America, Europe, and China. Tesaro is currently focused on commercializing products directly in North America, and directly or in partnership with established companies in Europe and China. The company's strategy is to identify, acquire, and develop promising drug candidates, and to commercialize cancer therapeutics that are potentially safer and more effective than existing treatments.

Copyright Berlingske Media 2018  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
17 December 2018 08:23:21
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20181207.1 - EUROWEB2 - 2018-12-17 09:23:21 - 2018-12-17 08:23:21 - 1000 - Website: OKAY